About Blue Marble Biomaterials
Blue Marble Biomaterials is a Chemicals & Materials company based in Missoula (United States) founded in 2007, and was acquired by Socati in May 2019. Specialty chemicals from biomass are produced using fermentation technology. Blue Marble Biomaterials has raised $5.21 million across 5 funding rounds from investors including DNRC and Socati. Its focus areas include Chemicals and Materials Tech, Chemicals Tech, Green Chemicals and Diversified. Its competitors include Manus Bio and P2 Science; 2 of its 2 listed competitors have raised funding.
Company details
Blue Marble Biomaterials was founded in 2007 in Missoula, United States, within the biotechnology sector. Proprietary polyculture fermentation is employed to convert biomass into specialty chemicals. The AGATE process integrates non-genetically modified bacteria across multiple species in a unified chain, breaking down plant material to yield compounds such as carotenoids, terpenes, oils, natural esters, organic acids, thiols, and sulfur-based substances. Development of a plant-derived vegan bacon flavor is underway.
- Headquarters Missoula, United States
- Stage Acquired
- SectorsChemicals & Materials
- Email••••••••
- Website bluemarblebio.com
- Social LinkedIn X Facebook
- Acquired by Socati (May 2019)
Funding Insights of Blue Marble Biomaterials
Blue Marble Biomaterials has successfully raised a total of $5.21M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3.23 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.21M
- Total Rounds 5
- Last Round Series A — $3.23M
- First Round $1M
(Jul 2009)
- Investors Count 1
All 5 funding rounds of Blue Marble Biomaterials with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | $3.23M | Series A | – | – | – |
| Jan 2012 | $90,000 | Series A | – | – | – |
| Jan 2011 | $894,782 | Series A | – | – | – |
| Nov 2010 | $30,000 | Grant | – | – | |
| Jul 2009 | $1M | Angel Round | – | – | – |
2 investors in total: 2 institutional.
Investors in Blue Marble Biomaterials
Blue Marble Biomaterials has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include DNRC and Socati.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Natural resources management and conservation services are provided in Montana. | dnrc.mt.gov | United States | ||
Hemp and cannabis-based medical products are manufactured. | 2011 | socati.com | Woodburn, United States |
Investor details for Blue Marble Biomaterials
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Blue Marble Biomaterials
4 dated milestones of Blue Marble Biomaterials across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Blue Marble Biomaterials is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series A, of $3.2M.
- Exit Acquired by Socati.
Competitors of Blue Marble Biomaterials
Blue Marble Biomaterials has 2 listed competitors in our database, 2 of them funded. They include Manus Bio and P2 Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| manusbio.com | 2011 | Cambridge, United States | $115.93M | Phytochemicals are developed using microbial fermentation processes. | ||
| p2science.com | 2011 | Woodbridge, United States | $39.16M | 1 | Diversified green chemicals are manufactured from bio-renewable resources. |
Detailed competitors of Blue Marble Biomaterials
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Chemicals Tech
3 companies that operate in the same segment as Blue Marble Biomaterials (Chemicals Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Microbe-based plant protection products and yield optimization services are provided. | 2013 | Boston, Massachusetts, United States | USD 1.4 B | 1,316 | ||
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | |||
Sustainable bio-based chemicals are manufactured using a proprietary platform. | 2016 | Houston, Texas, United States | USD 656.05 M | 133 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Blue Marble Biomaterials
Complete news archive for Blue Marble Biomaterials
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Blue Marble Biomaterials
Blue Marble Biomaterials was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Blue Marble Biomaterials is headquartered in Missoula, United States. It is registered at Missoula, Montana, United States.
Blue Marble Biomaterials is a funded company, having raised a total of $5.21M across 5 funding rounds to date. The company's 1st funding round was a Angel Round of $1M, raised on Jul 2009.
Blue Marble Biomaterials was founded in 2007 in Missoula, United States, within the biotechnology sector. Proprietary polyculture fermentation is employed to convert biomass into specialty chemicals. The AGATE process integrates non-genetically modified bacteria across multiple species in a unified chain, breaking down plant material to yield compounds such as carotenoids, terpenes, oils, natural esters, organic acids, thiols, and sulfur-based substances. Development of a plant-derived vegan bacon flavor is underway.
Blue Marble Biomaterials's top competitors include Manus Bio and P2 Science.
Yes. Blue Marble Biomaterials was acquired by Socati in May 2019.